InsiderClue
Insiders · Profile

Greenway Schond L.

Chief Financial Officer at Definium Therapeutics · CFO at Avalo Therapeutics. Filing since 10 Jun 2021. CIK 0001848205

DFTX Definium Therapeutics, Inc. Chief Financial Officer · 4 trades AVTX Avalo Therapeutics, Inc. CFO · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DFTX Definium Therapeutics, Inc.
26 Dec 2023
Chief Financial Officer
Sold at will
5,652
$20.52K
2.5%
DFTX Definium Therapeutics, Inc.
25 Sep 2023
Chief Financial Officer
Sold at will
5,762
$20.61K
2.5%
DFTX Definium Therapeutics, Inc.
25 Aug 2023
Chief Financial Officer
Sold at will
20,000
$76.00K
8.1%
DFTX Definium Therapeutics, Inc.
27 Jun 2023
Chief Financial Officer
Sold at will
11,635
$37.19K
4.5%
AVTX Avalo Therapeutics, Inc.
10 Dec 2021
CFO
Bought
2,231
$3.50K
135%
AVTX Avalo Therapeutics, Inc.
10 Jun 2021
CFO
Bought
652
$1.75K
65.2%
6 decisions on file.